Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain

NCT02866071 is registered in ClinicalTrials.gov with Jason McMullan as lead sponsor.

NCT NCT02866071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02866071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain
Lead sponsor
Jason McMullan
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 3, 2017
Completion date
December 31, 2022
Enrollment
224 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute traumatic pain